MRCP UK EXAMINATIONS

Detailed explanation-1: -Treatment of DVT (deep vein thrombosis) The main treatments include: blood-thinning medicines, such as warfarin or rivaroxaban – you’ll probably need to take these for at least 3 months. surgery to remove blood clots or stop them forming.

Detailed explanation-2: -These drugs are used in the prophylaxis of venous thromboembolic disease (VTE) on acute or elective admission to the hospital, and they are used in the treatment of deep vein thromboses (DVT) and pulmonary embolism (PE).

Detailed explanation-3: -LMWHs have several pharmacological advantages over UFH, including increased bioavailability, substantially reduced protein binding, and a prolonged half-life, allowing for once-daily dosing. These agents also have decreased interactions with platelets, which may reduce the risk of bleeding and HIT.

Detailed explanation-4: -First-line therapy for non-high risk venous thromboembolism (VTE) or pulmonary embolism (PE) consists of direct oral anticoagulants (dabigatran, rivaroxaban, apixaban, or edoxaban) over vitamin K antagonists (VKAs).